Geo News
Community curated by people like you
LatestAICryptoHealthWorld AffairsUS Politics
American Hospital Association sues HHS over 340B rebate pilot program
00

American Hospital Association sues HHS over 340B rebate pilot program

May 21, 2026

The American Hospital Association, Maine Hospital Association, and four safety-net hospitals sued HHS on October 9, 2026, to halt a 340B drug rebate pilot program set for January. The plaintiffs contend HRSA underestimated administrative burdens, warning true costs could top $1 billion annually and force hospital closures. Drugmakers cite $100 billion in 340B spending in 2025 as evidence of profiteering, while hospital leaders argue the rebates threaten safety-net care.

AHA lawsuit filing and plaintiffs

  • ▪The four safety-net hospital plaintiffs joining the AHA lawsuit against HHS are Eastern Maine Medical Center, Nathan Littauer Hospital and Nursing Home, Unity Medical Center, and Dallas County Medical Center.
  • ▪On October 9, 2026, the American Hospital Association, the Maine Hospital Association, and four safety-net hospitals sued HHS in Maine district court to pause HRSA's 340B rebate pilot program before its scheduled January implementation.

Allegations in AHA lawsuit

  • ▪The AHA complaint alleges HRSA's $537 million annual cost estimate for the 340B rebate pilot excludes IT, training, vendor, and reconciliation expenses that could push costs past $1 billion annually.
  • ▪The AHA lawsuit alleges HRSA advanced the 340B rebate pilot despite hundreds of public comments warning that the program could force hospital closures and harm patient access to care.

Overview of 340B program

  • ▪Congress established the federal 340B Drug Pricing Program in 1992 to allow health providers caring for low-income and uninsured populations to purchase outpatient drugs at 25% to 50% discounts.
  • ▪Hospitals and outpatient facilities purchased $100 billion worth of 340B drugs in 2025, representing a 23% increase from the prior year.

HRSA rebate pilot attempts

  • ▪A federal judge previously struck down HRSA's initial 340B rebate pilot attempt following a lawsuit by the American Hospital Association and the Maine Hospital Association.
  • ▪In summer 2026, HRSA announced a refreshed 340B rebate program that included more drug manufacturers and medications than its initial attempt.

Debatable claims

  • ▪HRSA should halt its 340B drug rebate pilot program
  • ▪Expanding 340B drug purchases is driven by hospital financial gain rather than patient need

2 sources

Healthcaredive
Hospitals sue over revamped 340B rebate pilot
View source article
Ajmc
CVS Health Sued Over Alleged Scheme to Siphon 340B Drug Program Savings | AJMC
View source article

Story comments

Loading comments…

Topics

Drug pricingFederal AI regulationHealthcare Policy